domingo, 22 de marzo de 2026

Making treatment for obesity more equitable The Lancet ++... ++

Making treatment for obesity more equitable The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00554-4/fulltext?dgcid=raven_jbs_etoc_email Mar 21, 2026 Volume 407Number 10534p1119-1208 https://www.thelancet.com/journals/lancet/issue/vol407no10534/PIIS0140-6736(26)X2009-8 Could engineered xenotransplantation end the organ shortage and save lives? February 23, 2026 • The Lancet https://www.buzzsprout.com/2593131/episodes/18655350-could-engineered-xenotransplantation-end-the-organ-shortage-and-save-lives Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial Julio Rosenstock, MDa,* juliorosenstock@dallasdiabetes.com ∙ Daisuke Yabe, MDb,c,d ∙ David Cox, PhDe ∙ Jianghao Li, PhDe ∙ Max Denning, MDe ∙ Wen-Shuo Wu, MDe ∙ et al. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00202-3/abstract?dgcid=raven_jbs_etoc_feature_lancet

No hay comentarios: